Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development (original) (raw)

• Brosius, F.C. III et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 20, 2503–2512 (2009).
  Article Google Scholar
• Nath, K.A., Salahudeen, A.K., Clark, E.C., Hostetter, M.K. & Hostetter, T.H. Role of cellular metabolites in progressive renal injury. Kidney Int. Suppl. 38, S109–S113 (1992).
  CAS PubMed Google Scholar
• Humphreys, B.D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85–97 (2010).
  Article CAS Google Scholar
• Zeisberg, M. et al. BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964–968 (2003).
  Article CAS Google Scholar
• Bielesz, B. et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J. Clin. Invest. 120, 4040–4054 (2010).
  Article CAS Google Scholar
• Kato, H. et al. Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival. J. Biol. Chem. 286, 26003–26015 (2011).
  Article CAS Google Scholar
• Fabian, S.L. et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am. J. Pathol. 180, 1441–1453 (2012).
  Article CAS Google Scholar
• Böttinger, E.P. & Bitzer, M. TGF-β signaling in renal disease. J. Am. Soc. Nephrol. 13, 2600–2610 (2002).
  Article Google Scholar
• DeBerardinis, R.J. & Thompson, C.B. Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148, 1132–1144 (2012).
  Article CAS Google Scholar
• Oldfield, M.D. et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Invest. 108, 1853–1863 (2001).
  Article CAS Google Scholar
• Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488–493 (2013).
  Article CAS Google Scholar
• Susztak, K., Ciccone, E., McCue, P., Sharma, K. & Bottinger, E.P. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med. 2, e45 (2005).
  Article Google Scholar
• Schug, T.T. & Li, X. Sirtuin 1 in lipid metabolism and obesity. Ann. Med. 43, 198–211 (2011).
  Article CAS Google Scholar
• Tran, M. et al. PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003–4014 (2011).
  Article CAS Google Scholar
• Proctor, G. et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55, 2502–2509 (2006).
  Article CAS Google Scholar
• Chau, B.N. et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci. Transl. Med. 4, 121ra118 (2012).
  Article Google Scholar
• Portilla, D. et al. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int. 69, 2194–2204 (2006).
  Article CAS Google Scholar
• Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M. & Gafter, U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J. Lipid Res. 55, 561–572 (2014).
  Article CAS Google Scholar
• Li, S. et al. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-α in mice confers protection during acute kidney injury. Kidney Int. 76, 1049–1062 (2009).
  Article CAS Google Scholar
• Declèves, A.E. et al. Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet–induced kidney injury. Kidney Int. 85, 611–623 (2014).
  Article Google Scholar
• Woroniecka, K.I. et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 60, 2354–2369 (2011).
  Article CAS Google Scholar
• Si, H. et al. Human and murine kidneys show gender- and species-specific gene expression differences in response to injury. PLoS ONE 4, e4802 (2009).
  Article Google Scholar
• Vielhauer, V. et al. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney Int. 66, 2264–2278 (2004).
  Article CAS Google Scholar
• Goldberg, I.J., Trent, C.M. & Schulze, P.C. Lipid metabolism and toxicity in the heart. Cell Metab. 15, 805–812 (2012).
  Article CAS Google Scholar
• Zavadil, J., Cermak, L., Soto-Nieves, N. & Bottinger, E.P. Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155–1165 (2004).
  Article CAS Google Scholar
• Kim, S.W. et al. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev. Biol. 357, 492–504 (2011).
  Article CAS Google Scholar
• Ko, Y.A. et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol. 14, R108 (2013).
  Article Google Scholar
• Kuhajda, F.P. et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. USA 97, 3450–3454 (2000).
  Article CAS Google Scholar
• Wanner, C., Drechsler, C. & Krane, V. Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk. J. Ren. Nutr. 17, 75–78 (2007).
  Article Google Scholar
• Kovesdy, C.P., Anderson, J.E. & Kalantar-Zadeh, K. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. J. Am. Soc. Nephrol. 18, 304–311 (2007).
  Article CAS Google Scholar
• Khan, S. et al. Lipotoxic disruption of NHE1 interaction with PI4,5P2 expedites proximal tubule apoptosis. J. Clin. Invest. 124, 1057–1068 (2014).
  Article CAS Google Scholar
• Meyer, C., Nadkarni, V., Stumvoll, M. & Gerich, J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am. J. Physiol. 273, E650–E654 (1997).
  CAS PubMed Google Scholar
• Li, B. et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513, 251–255 (2014).
  Article CAS Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).
• Yadav, H. et al. Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab. 14, 67–79 (2011).
  Article CAS Google Scholar
• Dugan, L.L. et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J. Clin. Invest. 123, 4888–4899 (2013).
  Article CAS Google Scholar
• Samudio, I. et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 120, 142–156 (2010).
  Article CAS Google Scholar
• Jun, M. et al. Effects of fibrates in kidney disease: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 60, 2061–2071 (2012).
  Article CAS Google Scholar
• Davis, T.M. et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 54, 280–290 (2011).
  Article CAS Google Scholar
• Ansquer, J.C. et al. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS). Am. J. Kidney Dis. 45, 485–493 (2005).
  Article CAS Google Scholar